Contrast injector firm Medrad has received a contract from the Joint Department of Medical Imaging of the University Health Network (UHN)/Mount Sinai Hospital/Women's College Hospital (WCH) in Toronto.
Medrad will serve as the Canadian healthcare system's contract supplier for vascular injections used in CT, MR, and cardiovascular imaging procedures, as well as for MR patient monitoring systems, according to the Warrendale, PA-based vendor.
By AuntMinnie.com staff writers
July 10, 2007
Related Reading
Medrad grows revenues, workforce, March 20, 2007
Road to RSNA, Medrad, November 1, 2006
Consorta launches group buy promotions, October 31, 2006
Road to RSNA, Medrad, October 26, 2006
Medrad introduces Certo wireless system, October 16, 2006
Copyright © 2007 AuntMinnie.com
![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
